glp 1 perimenopause weight gain Are you navigating menopause while considering GLP-1 treatments? You're not alone in having questions. With so much conflicting information out there, it's crucial to distinguish between myths and evidence-based facts. From hormone Are GLP-1's a Cure for
Description
Background Establishing whether there is a potential relationship between glucagon-like peptide 1 receptor agonists (GLP-1RAs) and suicidal or self-injurious behaviors (SSIBs) is crucial for public safety
Learn why some patients cannot tolerate these medications and when endoscopic sleeve may be considered.
Discover proper techniques for current injectable GLP-1 medications and what to know about future transdermal delivery systems.
Results Patients with a high cumulative dose of GLP-1 agonist are associated with a higher risk of developing drug-induced pancreatitis associated with GLP-1 agonists, indicated by a statistically significant odds ratio
An editorial review of Agile Health business model, compounded-pharmacy pathway, patient reports, and fair-balance safety
In this narrative review we introduce the preclinical data related to this receptor pathway and pancreatic ductal adenocarcinoma
